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A
ddiction Science & Clinical Practice (AS&CP) is about 
to enter a new stage in its development. 
After this issue, the journal moves to a new publisher, 
Biomed Central, and assumes a new format as an open-
access, Internet-only publication. Taking over as Editors 
are Richard Saitz, M.D., M.P.H., and Jeffrey Samet, M.D., 
M.A., M.P.H., of the Clinical Addiction Research and Educa-
tion Unit at Boston Medical Center and Boston University 
School of Medicine and School of Public Health.
AS&CP was launched in 2002 with its original title, 
Science & Practice Perspectives. The journal was a key com-
ponent of NIDA’s response to a challenge issued by the 
Institute of Medicine (IOM). The IOM had identified a gap 
between substance abuse research and practice as a major 
obstacle to progress and called upon the field to close it. 
NIDA’s new peer-reviewed journal set out to foster rich, 
creative exchanges between researchers and clinicians. 
That goal informed its every aspect— its diverse editorial 
board, article selection, additional features, style, design, 
and layout. 
In its 9 years under the outstanding leadership of Found-
ing Editor David Anderson, M.S., AS&CP has proved that 
the field values that mission and product. Top authorities 
at bench and clinic have welcomed the opportunity and 
the challenge of imparting their knowledge across the 
research-practice divide, with special attention to practical 
implications and constructive advice. Response panels in 
which clinicians and researchers engage in free give and 
take in reaction to a particular article have been among the 
journal’s most distinctive and popular features. AS&CP 
has more subscribers than any other addiction journal, 
and articles have been translated into several languages. 
At its new home, AS&CP will be well placed to continue 
to advance the research-practice interchange. Drs. Saitz and 
Samet are experienced editors who spend every working 
day at the interface of the creation of new knowledge and its 
application. In their hands, the journal has a bright future.
Nora D. Volkow, M.D.
Director
National Institute on Drug Abuse